Cargando…

Cannabinoid as Beneficial Replacement Therapy for Psychotropics to Treat Neuropsychiatric Symptoms in Severe Alzheimer’s Dementia: A Clinical Case Report

Alzheimer’s Dementia (AD) is a devastating neurodegenerative disease that affects approximately 17% of people aged 75–84. Neuropsychiatric symptoms (NPS) such as delusions, agitation, anxiety, and hallucinations are present in up to 95% of patients in all stages of dementia. To date, any approved an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Defrancesco, Michaela, Hofer, Alex
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238747/ https://www.ncbi.nlm.nih.gov/pubmed/32477187 http://dx.doi.org/10.3389/fpsyt.2020.00413

Ejemplares similares

Prenatal Cannabinoid Exposure: Emerging Evidence of Physiological and Neuropsychiatric Abnormalities
por: Nashed, Mina G., et al.
Publicado: (2021)

Anosognosia in Early- and Late-Onset Dementia and Its Association With Neuropsychiatric Symptoms
por: Tondelli, Manuela, et al.
Publicado: (2021)

What evidence is there for implicating the brain orexin system in neuropsychiatric symptoms in dementia?
por: Bergamini, Giorgio, et al.
Publicado: (2022)

Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders
por: Ishiguro, Hiroki, et al.
Publicado: (2022)

Medical cannabinoids for treatment of neuropsychiatric symptoms in dementia: a systematic review
por: Stella, Florindo, et al.
Publicado: (2021)

A Comparison of Acute Neurocognitive and Psychotomimetic Effects of a Synthetic Cannabinoid and Natural Cannabis at Psychotropic Dose Equivalence
por: Theunissen, Eef Lien, et al.
Publicado: (2022)

Neuropsychiatric symptoms and severity of dementia
por: Caldas, Gustavo Henrique de Oliveira, et al.
Publicado: (2013)

Neuropsychiatric Symptoms in Elderly With Dementia During COVID-19 Pandemic: Definition, Treatment, and Future Directions
por: Simonetti, Alessio, et al.
Publicado: (2020)

Neuropsychiatric Symptoms and Their Association With Sex, Age, and Enzyme Replacement Therapy in Fabry Disease: A Systematic Review
por: Mroczek, Magdalena, et al.
Publicado: (2022)

Neuropsychiatric Symptoms in Mild Cognitive Impairment and Dementia Due to AD: Relation With Disease Stage and Cognitive Deficits
por: Wiels, Wietse A., et al.
Publicado: (2021)

Safety and effectiveness of cannabinoids for the treatment of neuropsychiatric symptoms in dementia: a systematic review
por: Hillen, Jodie Belinda, et al.
Publicado: (2019)

Principles and management of neuropsychiatric symptoms in Alzheimer’s dementia
por: Nowrangi, Milap A, et al.
Publicado: (2015)

Probing the relevance of the accelerated aging mouse line SAMP8 as a model for certain types of neuropsychiatric symptoms in dementia
por: Bergamini, Giorgio, et al.
Publicado: (2023)

Neuropsychiatric Symptoms in Parkinson’s Disease: Beyond Complications
por: Kehagia, Angie A.
Publicado: (2016)

Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia
por: Lee, Philip E, et al.
Publicado: (2006)

The Impact of COVID-19 Infection and Enforced Prolonged Social Isolation on Neuropsychiatric Symptoms in Older Adults With and Without Dementia: A Review
por: Manca, Riccardo, et al.
Publicado: (2020)

Case series of drug-induced open bite: Extrapyramidal symptoms related to psychotropic medications
por: Watanabe, Motoko, et al.
Publicado: (2023)

Psychotropic Medication and Substance Use during Pregnancy by Women with Severe Mental Illness
por: Brameld, Kate J., et al.
Publicado: (2017)

Editorial: The affective side of Alzheimer's disease (AD): neuropsychiatric symptoms as early sentinel of cognitive decline and pathogenetic factors in disease progression
por: Cutuli, Debora, et al.
Publicado: (2023)

Disturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric Symptoms
por: Gostner, Johanna M., et al.
Publicado: (2015)

SPECT findings on neuropsychiatric symptoms caused by nitrous oxide abuse
por: Wang, Li, et al.
Publicado: (2022)

CB(2) Cannabinoid Receptor As Potential Target against Alzheimer's Disease
por: Aso, Ester, et al.
Publicado: (2016)

Synthetic Cannabinoids and Its Association With Persistent Negative Symptoms of Schizophrenia
por: Satodiya, Ritvij, et al.
Publicado: (2020)

Evaluating the Clinical Impact of National Dementia Behaviour Support Programs on Neuropsychiatric Outcomes in Australia
por: Macfarlane, Stephen, et al.
Publicado: (2021)

Recurrent Severe Burns Due to Cannabinoid Hyperemesis Syndrome
por: Osagie, Eugene, et al.
Publicado: (2023)

Neuropsychiatric Symptoms Exacerbate the Cognitive Impairments in Patients With Late-Life Depression
por: Zhang, Min, et al.
Publicado: (2021)

Neuropsychiatric symptoms and altered sleep quality in cerebral small vessel disease
por: Li, Xi, et al.
Publicado: (2022)

Editorial: Safety and side effects of psychotropic medications
por: de Filippis, Renato, et al.
Publicado: (2023)

Cardiometabolic Effects of Antipsychotics in Challenging Behavior and Neuropsychiatric Symptoms in Patients With Intellectual Disability
por: Takano, Tomoyuki
Publicado: (2023)

Neuropsychiatric symptoms in cognitively normal older persons, and the association with Alzheimer’s and non-Alzheimer’s dementia
por: Liew, Tau Ming
Publicado: (2020)

Association Between Caregivers’ Burden and Neuropsychiatric Symptoms in Female Patients with Alzheimer’s Disease with Varying Dementia Severity
por: Chen, Yu-An, et al.
Publicado: (2021)

Synergistic Effects of Psychotropics Leading to Extraordinary Weight Gain
por: Kemp, Allyson J, et al.
Publicado: (2021)

Effect of the COVID-19 pandemic on the psychotropic drug consumption
por: Benistand, Paul, et al.
Publicado: (2022)

Case Report: PANDAS and Persistent Lyme Disease With Neuropsychiatric Symptoms: Treatment, Resolution, and Recovery
por: Cross, Amy, et al.
Publicado: (2021)

A Case of Neuropsychiatric Systemic Lupus Erythematosus With Hair Loss as the First Diagnostic Symptom
por: He, Xun, et al.
Publicado: (2022)

Time Perception in Prodromal Alzheimer's Dementia and in Prodromal Dementia With Lewy Bodies
por: Pai, Ming-Chyi, et al.
Publicado: (2021)

Cannabis/Cannabinoids for Treating COVID-19 Associated Neuropsychiatric Complications
por: Khalsa, Jag H., et al.
Publicado: (2021)

Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis
por: Eikelboom, Willem S., et al.
Publicado: (2022)

Associations between neuropsychiatric symptoms and incident Alzheimer’s dementia in men versus women
por: Liampas, Ioannis, et al.
Publicado: (2022)

Why Psychotropic Drugs Don't Cure Mental Illness—But Should They?
por: Ivanov, Iliyan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hnpudmjp0kigvplvd5t0t6n72u